The neutrophil and preeclampsia

Seminars in Reproductive Endocrinology

Volumn 16, Issue 1, 1998, Pages 57-64

  Clark, Peter ^a   Boswell, Fiona ^a   Greer, Ian A ^a  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

Neutrophil; Preeclampsia; Pregnancy

Indexed keywords

CELL ADHESION MOLECULE; CYTOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENDOTHELIN 1; INTEGRIN; INTERLEUKIN 6; LEUKOCYTE ELASTASE; LIPID; LIPOPROTEIN; NITRIC OXIDE; PADGEM PROTEIN; THROMBOCYTE ACTIVATING FACTOR; TUMOR NECROSIS FACTOR ALPHA;

CYTOKINE RELEASE; ENDOTHELIUM INJURY; HUMAN; LEUKOCYTE ACTIVATION; NEUTROPHIL; PATHOGENESIS; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; THROMBOCYTE;

EID: 0031799997     PISSN: 07348630     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1016253     Document Type: Review

References (98)

1. Khong TY, de Wolf F, Robertson WB, et al. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestation-age infants. Br J Obstet Gynaecol 1986;93:1049
2. Zeek PM, Assali NS. Vascular changes with eclamptogenic toxemia of pregnancy. Am J Obstet Gynecol 1950;20:1099
3. Labarrere CA. Acute atherosis. A histopathological hallmark of immune aggression. Placenta 1988;9:95
4. Moll E, Kinzel W, Hoberger J. Haemodynamic implications of haemochorial placentations. Eur J Obstet Gynecol Reprod Biol 1975;5:67
5. Lyall F, Greer IA. Pre-eclampsia: a multifaceted vascular disorder of pregnancy, [Review][87 refs]. J Hypertens 1994;12:1339
6. Redman CWG, Allington MJ, Bolton FG, Stirrat GM. Plasma beta thromboglobulin in pre-eclampsia. Lancet 1977;2:248
7. Douglas JT, Shah M, Lowe GDO, et al. Plasma fibrinopeptide A and beta thromboglobulin in pre-eclampsia and pregnancy hypertension. Thromb Haemostas 1982;47:54
8. Greer IA, Calder AA, Walker JJ, Lunan CB, Tulloch I. Increased platelet reactivity in pregnancy-induced hypertension and uncomplicated diabetic pregnancy: an indication for anteplatelet therapy? Br J Obstet Gynaecol 1988;5:1204
9. Greer IA, Leask R, Hodson BA, et al. Endothelin, elastase and endothelial dysfunction in pre-eclampsia. Lancet 1991:558
10. Downing I, Shepherd GL, Lewis PJ. Reduced prostacyclin production in pre-eclampsia [Letter]. Lancet 1980:1374
11. Walsh SW. Pre-eclampsia: an imbalance in placental prostacyclin and thromboxane production. Am J Obstet Gynecol 1985;152:335
12. Howie P, Prentice CRM, McNicol GP. Coagulation, fibrinolysis and platelet function in pre-eclampsia, essential hypertension and placental insufficiency. J Obstet Gynaecol Br Commonw 1971;78:992
13. Brenner B, Lanir N, Thaler I. HELLP syndrome associated with factor V R 506Q mutation. Br J Haematol 1996;92:999
14. Dekker GA, de Vries JI, Doelitzsch PM, et al. Underlying disorders associated with severe early-onset preeclampsia. Am J Obstet Gynecol 1995;173:1042
15. Harlan JD. Neutrophil-mediated vascular injury. Acta Med Scand 1987;715(Suppl):123
16. Bray MA. The pharmacology and pathophysiology of leukotriene B4. Br Med Bull 1984;39:249
17. Thiagarajan RR, Winn RK, Harlan JM. The role of leucocyte and endothelial adhesion molecules in ischemia-reperfusion injury. Thromb Haemostas 1997;78:310
18. Lawrence MB, Springer TA. Neutrophils roll on E-selectin. J Immunol 1993;151:6338
19. McEver RP, Moore KL, Cummings RD. Leukocyte trafficking mediated by selectin-carbohydrate interactions [Review][93 refs]. J Biol Chem 1995;270:11025
20. Haller H, Ziegler EM, Hormuth V, et al. Endothelial adhesion molecules and leukocyte integrins in pre-eclamptic patients. Hypertension 1997;29:291
21. Smith CW, Marlin SD, Rothlein R, Toman C, Anderson DC. Cooperative interactions of LFA-1 and Mac-1 with intracellular adhesion molecule-1 in facilitating adherence and transendothelial migration of human neutrophils in-vitro. J Clin Invest 1989;83:2008
22. Hynes RO, Bader BL. Targeted mutations in integrins and their ligands: their implications for vascular biology. Thromb Haemostas 1997;78:83
23. Smith WB, Gamble JR, Clark-Lewis I, Vadas MA. Chemotactic desensitization of neutrophils demonstrates interleukin-8 (IL-8)-dependent and IL-8-independent mechanisms of transmigration through cytokine-activated endothelium. Immunology 1993;78:491
24. Vaporciyan AA, DeLisser HM, Yan HC, et al. Involvement of platelet-endothelial cell adhesion molecule-1 in neutrophil recruitment in vivo. Science 1993;262:1580
25. Muller WA, Weigl SA, Deng X, Phillips DM. PECAM-1 is required for transendothelial migration of leukocytes. J Exp Med 1993;178:449
26. Elices MJ, Osborn L, Takada Y, et al. VCAM-1 on activated endothelium interacts with the leucocyte integrin VLA4 at a site distinct from the VLA4/fibronectin binding site. Cell 1990;60:577
27. Kubes P. Polymorphonuclear leukocyte-endothelium interactions: a role for pro-inflammatory and anti-inflammatory molecules [Review]. Can J Physiol Pharmacol 1993;71:88
28. Smith CW, Kishimoto TK, Abbassi O, et al. Chemotactic factors regulate lectin adhesion molecule 1 (LECAM-1)- dependent neutrophil adhesion to cytokine-stimulated endothelial cells in vitro. J Clin Invest 1991;87:609
29. Ley K, Gaehtgengs P, Fennie C, Singer MS, Lasky LA, Rosen SD. Lectin-like cell adhesion molecule 1 mediates leukocyte rolling in mesenteric venules in vivo. Blood 1991;77:2553
30. Kishimoto TK, Jutila MA, Berg EL, Butcher EC. Neutrophil Mac-1 and MEL-14 adhesion proteins inversely regulated by chemotactic factors. Science 1989;245:1238
31. Furie MB, Burns MJ, Tancinco MCA, Benjamin CD, Lobb RR. E-selectin (endothelial-leukocyte adhesion molecule-1) is not required for the migration of neutrophils across IL-1 stimulated endothelium in vitro. J Immunol 1992;148:2395
32. Kishimoto TK, Warnock RA, Jutila MA, et al. Antibodies against human neutrophil LECAM-1 (LAM-1/Leu-8/DREG-56 antigen) and endothelial cells ELAM-1 inhibit a common CD-18 independent adhesion pathway in-vitro. Blood 1991;78:805
33. McIntyre TM, Modur V, Prescott SM, Zimmerman GA. Molecular mechanisms of early inflammation. Thromb Haemostas 1997;78:302
34. Subramanian M, Koedam JA, Wagner DD. Divergent fates of P- and E-selectins after their expression on the cell membrane. Molec Biol Cell 1993;4:791
35. Whately RE, Zimmerman GA, Prescott SM, McIntyre TM. Platelet-activating factor and PAF-like mimetics. In Bell RM (ed). Handbook of lipid research, vol. 8: lipid second messengers. New York: Plenum Press, 1996:239
36. Garela JGN, Azghani A, Callahan KS, Johnson AR. Effect of platelet activating factor on leukocyte endothelial cell interactions. Thromb Res 1988;51:83
37. Lorant DE, Topham MK, Whatley RE, et al. Inflammatory roles of P-selectin. J Clin Invest 1993;92:559
38. Zimmerman GA, Prescott SM, McIntyre TM. Endothelial cell interactions with granulocytes: tethering and signalling molecules. Immunol Today 1992;13:93
39. Lo SK, Lee S, Ramos RA, et al. Endothelial-leukocyte adhesion molecule 1 stimulates the adhesive activity of leukocyte integrin CR3 (CD11b/CD18, MAC-1) on human neutrophils. J Exp Med 1991;173:1493
40. Greer IA, Haddad NG, Dawes J, Johnstone FD, Calder AA. Neutrophil activation in pregnancy-induced hypertension. Br J Obstet Gynaecol 1989;96:978
41. Barden A, Graham D, Beilin LJ, et al. Neutrophil CD11B expression and neutrophil activation in pre-eclampsia. Clin Sci 1997;92:37
42. Sacks GP, Studena K, Sargent IL, Redman CWG. Normal pregnancy and pre-eclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Presentation to The International Society for the Study of Hypertension in Pregnancy. Lady Margaret Hall, Oxford, UK., Sept 3-5, 1997
43. Greer IA, Dawes J, Johnston TA, Calder AA. Neutrophil activation is confined to the maternal circulation in pregnancy-induced hypertension. Obstet Gynecol 1991;78:28
44. Janoff A. Elastase in tissue injury. Ann Rev Med 1985;36:207
45. Greer IA, Haddad NG, Dawes J, Johnston TA, Johnston FD, Steel JM. Increased neutrophil activation in diabetic pregnancy and in non-pregnant diabetic women. Obstet Gynecol 1989;74:878
46. Butterworth B, Greer IA, Liston WD, Haddad NG, Johnston TA. Immunocytochemical localization of neutrophil elastase in term placenta decidua and myometrium in pregnancy-induced hypertension. Br J Obstet Gynaecol 1991;98:929
47. Clark CJ, Chettibi S, Young JD, Greer IA, Lyall F. Locomotion of human neutrophils in response to plasma and serum of women with pre-eclampsia. Hypertens Pregnancy 1996;15:229
48. Harlan JM, Liu DY. Adhesion: its role in inflammatory disease. London: Freeman, 1992
49. Gearing AGH, Newman W. Circulating adhesion molecules in disease. Immunol Today 1993;14:506
50. Lyall F, Greer IA, Boswell F, Macara LM, Walker JJ, Kingdom JC. The cell adhesion molecule, VCAM-1, is selectively elevated in serum in pre-eclampsia: does this indicate the mechanism of leucocyte activation?. B J Obstet Gynaecol 1994;101:485
51. Austgulen R, Lien E, Vince G, Redman CWG. Increased maternal plasma levels of soluble adhesion molecules (ICAM-1, VCAM-1, E-selectin) in pre-eclampsia. Eur J Obstet Gynecol Repro Biol 1997;71:53
52. Sattar N, Bendomir A, Berry C, Shepherd J, Greer IA, Packard CJ. Lipoprotein subfraction concentrations in preeclampsia: pathogenic parallels to atherosclerosis. Obstet Gynecol 1997;89:403
53. Dustin ML, Rotlein R, Bhan AK, Dinarello CA, Springer TA. Induction by IL-1 and interferon gamma: tissue distribution, biochemistry and function of a natural adherence molecule ICAM-1. J Immunol 1986;137:245
54. Mattila P, Majuri M-L, Mattila PS, Ronkonen R. TNF alpha induced expression of endothelial adhesion molecules ICAM-1 and VCAM-1 is linked to protein kinase C activation. Scand J Immunol 1992;36:159
55. Kupferminc MJ, Peaceman AM, Wigton TR, Rhenberg KA, Socol ML. Tumor necrosis factor alpha is elevated in plasma and amniotic fluid of patients with severe preeclampsia. Am J Obstet Gynecol 1994;170:1752
56. Vince GS, Starkey PM, Austgulen R, Kwiatkowski D, Redman CWG. Interleukin-6, tumour necrosis factor and soluble tumour necrosis factor receptors in women with preeclampsia. Br J Obstet Gynaecol 1995;102:20
57. Greer IA, Lyall F, Perera T, Boswell F, Macara LM. Increased concentrations of cytokines interleukin-6 and interleukin-1 receptor antagonist in plasma of women with preeclampsia: a mechanism for endothelial dysfunction? Obstet Gynecol 1994;84:937
58. Kupferminc MJ, Peaceman AM, Aderka D, Wallach D, Socol ML. Soluble tumor necrosis factor receptors and interleukin-6 levels in patients with severe pre-eclampsia. Obstet Gynecol 1996;88:420
59. Wong GHW, Elwell JH, Oberley LW, Goeddel DV. Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumour necrosis factor. Cell 1989;58:923
60. Wang Y, Walsh SW. TNF alpha concentrations and mRNA expression are increased in pre-eclamptic placentas. J Repro Immunol 1996;32:157
61. Gamble JR, Harlan JM, Klebanoff SJ, Vadas MA. Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor. Proc Natl Acad Sci USA 1985;82:8667
62. Peveri P, Waltz A, Dewald B, Baggiolini M. A novel neutrophil-activating factor produced by human mononuclear phagocytes. J Exp Med 1988;167:1547
63. Varani J, Bendelow MJ, Sealey DE, et al. Tumour necrosis factor enhances susceptibility of vascular endothelial cells to neutrophil mediated killing. Lab Invest 1988;59:292
64. Tsukimori K, Maeda H, Ishida K, Nagata H, Koyanagi T, Nakano H. The superoxide generation of neutrophils in normal and preeclamptic pregnancies. Obstet Gynecol 1993;81:536
65. Bochner BS, Luscinskas FW, Gimbrone MA Jr, et al. Adhesion of human basophils, eosinophils, and neutrophils to interleukin 1-activated human vascular endothelial cells: contributions of endothelial cell adhesion molecules. J Exp Med 1991;173:1553
66. Borish L, Rosenbaum R, Albury L, Clark S. Activation of neutrophils by interleukin 6. Cell Immunol 1989;121:280
67. Stewart DJ, Monge JC. Hyperlipidaemia and endothelial dysfunction. Curr Opin Lipidol 1993;4:319
68. Gianturco SH, Eskin SG, Navarro LT, et al. Abnormal effects of hyperlriglycerloemic very low density lipoproteins on 3-hydroxy-methylglutaryl-CoA reductase actvity and viability of bovine cultured endothelial cells. Biochim Biophys Acta 1980;618:143
69. Spiedel MT, Booyse FM, Abrams A, Moore MA, Chung BH. Lipolysed hypertriglyceridemic serum and triglyceriderich lipoprotein cause lipid accumulation in and are cytotoxic to cultured human endothelial cells. High density lipoprotein inhibits this cytotoxicity. Thromb Res 1990;58:251
70. Silliman K, Shore V, Forte T. Hypertriglyceridaemia during late pregnancy is associated with the formation of small low-density lipoprotein and the presence of large buoyant high-density lipoproteins. Metabolism 1994;43:1035
71. Martin-Hidalgo A, Horn C, Belfrage M, Schotz MC, Herrera E. Lipoprotein-lipase and hormone-sensitive lipase activity and mRNA. Am J Physiol 1994;266:930
72. Grimbert S, Fromenty B, Fisch C, et al. Decreased mitochondrial oxidation of fatty acids in pregnant mice: possible relevance to the development of acute fatty liver of pregnancy. Hepatology 1993;17:628
73. O'Sullivan AJ, Hoffman DM, Ho KKY. Estrogen, lipid oxidation and body fat. N Engl J Med 1995;333:669
74. Lorentzen B, Endersen MJ, Clausen T, Henriksen T. Fasting serum free fatty acids and triglycerides are increased before 20 weeks of gestation in women who later develop preeclampsia. Hypertens Pregnancy 1994;13:103
75. Endersen MJ, Lorentzen B, Henriksen T. Increased lipolytic activity and high ratio of free fatty acids to albumin in sera from women with pre-eclampsia leads to triglyceride accumulation in cultured endothelial cells. Am J Obstet Gynecol 1992;167:440
76. Sattar N, Greer IA, Louden J, et al. Lipoprotein subfraction changes in normal pregnancy: threshold effect of plasma triglyceride on appearance of small, dense low density lipoprotein. J Clin Endocrinol Metab 1997;82:2483
77. Lehr HA, Krombach F, Munzing S, et al. In vitro effects of oxidized low density lipoprotein on CD11b/CD18 and L-selectin presentation on neutrophils and monocytes with relevance for the in vivo situation. Am J Pathol 1995;146:218
78. Kume N, Cybulsky MI, Gimbrone MA. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J Clin Invest 1992;90:1138
79. Lorentzen B, Endresen MJ, Hovig T, Haug E, Henriksen T. Sera from pre-eclamptic women increase the content of triglycerides and reduce the release of prostacyclin in cultured endothelial cells. Thromb Res 1991;63:353
80. Redman CWG, Bonnar J, Beilin LJ. Early platelet consumption in pre-eclampsia. Br Med J 1978;1:467
81. Rakoczi I, Tallian F, Bagdany S, Gati I. Platelet life-span in normal pregnancy and pre-eclampsia as determined by a non-radioisotope technique. Thromb Res 1979;15:553
82. Redman CWG, Allington MJ, Bolton FG, Stirrat GM. Plasma Beta-thromboglobulin in pre-eclampsia (letter). Lancet 1977;2:248
83. Douglas JT, Shah M, Lowe GDO, Belch JJF, Forbes CD, Prentice CRM. Plasma fibrinopeptide A and betathromboglobulin in pre-eclampsia and pregnancy hypertension. Thromb Haemostas 1982;47:54
84. Ware JA, Heistad DD. Platelet-endothelial interactions. N Engl J Med 1993;328:628
85. Clark BA, Halverson L, Sachs B, Epstein F. Plasma endothelin levels in pre-eclampsia: elevation and correlation with uric acid levels and renal impairment. Am J Obstet Gynecol 1992;166:962
86. Lopez-Farre A, Riesco A, Moliz M, et al. Inhibition by L-arginine of endothelin-mediated increase in cytosolic calcium in human neutrophils. Biochem Biophys Res Comm 1991;178:884
87. Ishida K, Takeshige K, Minakami S. Endothelin-1 enhances superoxide generation of human neutrophils stimulated by the chemotactic peptide N-formyl-methionylleucyl-phenylalanine. Biochem Biophys Res Comm 1990;173:496
88. Riesco A, Carmelo C, Blum G, et al. Nitric oxide-generating system as an autocrine mechanism in human polymorphonuclear leukocytes. Biochem J 1993;292:791
89. Gomez-Garre D, Guerra M, Gonzalez E, et al. Aggregation of human polymorphonuclear leukocytes by endothelin. Eur J Pharmacol 1992;224:167
90. Lopez-Farre A, Riesco A, Espinosa G, et al. Effect of endothelin-1 on neutrophil adhesion to endothelial cells and the perfused heart. Circulation 1993;88:1166
91. Cunningham ME, Huribal M, Bala RJ, McMillen MA. Endothelin-1 and endothelin-4 stimulate monocyte production of cytokines. Crit Care Med 1997;25:958
92. Baggiolini M, Waltz A, Kunel SL. Neutrophil activating protein 1/interleukin-8, a novel cytokine that activates neutrophils. J Clin Invest 1989;84:1045
93. Lopez-Farre A, Caramelo C, Estabar A, et al. Effects of aspirin on platelet neutrophil interactions. Role of nitric oxide and endothelin-1. Circulation 1995;91:2080
94. Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 1991;88:4651
95. Kubes P, Granger DN. Nitric oxide modulates microvascular permeability. Am J Physiol 1992;7:H611
96. Fickling SA, Williams D, Vallance P, Nussey SS, Whitley GSJ. Plasma concentrations of endogenous inhibitor of nitric acid oxide synthesis in normal pregnancy and preeclampsia. Lancet 1993;342:242
97. Cameron IT, van Papendorp CL, Palmer RMJ, Smith SK, Moncada S. Relationship between nitric oxide synthesis and increase in systolic blood pressure in women with hypertension in pregnancy. Hypertens Pregnancy 1993;12:91
98. Lyall F, Young A, Greer IA. Nitric oxide concentrations are increased in the fetoplacental circulation in pre-eclampsia. Am J Obstet Gynecol 1995;173:714